| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| CMPI | Checkmate Pharmaceuticals, Inc. | Director | May 31, 2022 | |||
| MBRX | Moleculin Biotech, Inc. | Director | Nov 4, 2024 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|